NYSE: EVMN
Evommune Inc Earnings Dates, Reports, Calls

Evommune earnings were N/A for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest EVMN earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$12.5M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EVMN reported annual earnings of -$68.3M, with 100.6% growth. The next EVMN earnings date is Mar 26, 2026.

EVMN earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

EVMN Return on Equity

Insufficient data to display

EVMN Return on Assets

Insufficient data to display

Be the first to know when EVMN announces earnings.

EVMN Return on Capital Employed

Current Company
0%
Current Industry
-3.5%

EVMN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EVMNN/AN/AN/AN/A
KROS$74.95M$64.45MN/A$1.60
SLS-$25.35M-$25.94MN/A-$0.28
IVA-$122.05M-$361.70MN/A-$4.37
PROK-$61.02M-$71.03MN/A-$0.55

EVMN earnings dates

Next earnings date
Mar 26, 2026

Evommune Earnings Reports & History FAQ

What were Evommune's earnings last quarter?

Evommune (NYSE: EVMN) reported Q3 2025 earnings per share (EPS) of -$8.07, up 22.92% year over year. Total EVMN earnings for the quarter were -$12.48 million. In the same quarter last year, Evommune's earnings per share (EPS) was -$10.47.

If you're new to stock investing, here's how to buy Evommune stock.

When does Evommune report earnings?

The next EVMN earnings call is Invalid Date. Add EVMN to your watchlist to be reminded of Evommune's next earnings date.

Is Evommune profitable or losing money?

As of the last Evommune earnings report, Evommune is currently losing money. Evommune's net profit (also called net income) for the twelve months ending Sep 30, 2025 was N/A, a N/A decrease year over year.

What was EVMN's earnings growth in the past year?

As of Evommune's earnings date in Q1 2026, Evommune's earnings has grown year over year. EVMN earnings in the past year totalled N/A.

What are Evommune's earnings expectations?

The current EPS estimate for Evommune's earnings report in Invalid Date is -$0.84.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.